Press KitSandoz, the generic pharmaceuticals division of Novartis, is a global leader in the rapidly growing generics industry. The company, with nearly 26,000 employees, offers a broad portfolio of approximately 1 100 high-quality, affordable molecules across all major therapeutic areas and approximately 140 countries, and is a global leader in differentiated products. Today, Sandoz is one of the two largest global generic companies, with leading positions across the largest pharmaceutical markets worldwide.
Frequently Asked Questions
Everything you wanted to know about the generics industry.